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Congenital intrahepatic portosystemic venous shunts are rare vascular malformations often associated with severe complications.
We describe a term male infant with Down syndrome with high output heart failure secondary to a congenital arterial to portal
venous fistula that was diagnosed by Doppler ultrasound. Percutaneous embolizations of the left hepatic vein, portal vein, and
communicatingfistulaswereperformedwithoutcomplications,resultinginclinicalimprovement.Asubsequenthepaticultrasound
demonstrated resolution of the pathologic fistulous communication and shunting effects.
1. Introduction
Congenital portosystemic shunts (CPSS) have been classified
into extrahepatic and intrahepatic based on the location
of the shunts [1]. These vascular malformations can be
detected by ultrasonography (US), computed tomography
(CT)scan,andmagneticresonance(MR)angiography.Com-
plications of CPSS may manifest in early infancy or later in
life, including neonatal hyperammonemia, cholestasis, hype-
rgalactosemia, liver tumors (benign or malignant), porto-
systemic encephalopathy, pulmonary arterial hypertension,
right heart failure, and hepatopulmonary syndrome [2]. We
r e p o r tt h ec a s eo fa ni n f a n tw i t hD o w ns y n d r o m ep r e s e n t -
ing with high output cardiac failure discovered to be due
to intrahepatic CPSS who was successfully treated with a
percutaneous embolization procedure.
2. Case Report
A term, 2662 grams (6.6 percentile), small for gestational
age male infant born by spontaneous vaginal delivery at
an outside institution, developed hypoxic respiratory failure
requiring continuous positive pressure ventilation. His pre-
natal history was significant for intrauterine growth restric-
tion, trisomy 21 (47, XY, +21) diagnosed by amniocentesis,
andareportedlynormalfetalechocardiogram.Ondayofage
2, he was noted to have an increasing pre- and postductal
saturations differential, requiring a FiO2 of 0.8 by nasal
cannula to keep his oxygen saturations 95%. A limited
echocardiogram was concerning for persistent pulmonary
hypertension (PPHN), demonstrating exclusive right to left
d u c t a ls h u n t i n gw i t had i l a t e dr i g h ta t r i u ma n dr i g h tv e n -
tricle, so the infant was placed on inhaled nitric oxide at
20 parts per million, which increased his pre- and post-
ductal saturations. Additionally, a dilated vascular hepatic
structure with continuous flow was noted on ultrasound.
Due to persistent respiratory distress, the infant was intu-
bated, placed on mechanical ventilation, and transferred to
our institution for further evaluation of his suspected liver
vascular malformation.
Physical examination was significant for Down syn-
drome facies and hypotonia. Cardiovascular exam revealed
an accentuated precordial impulse and a faint continuous
murmur audible at the left axilla. Pulses were diminished.2 Case Reports in Vascular Medicine
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Figure 1: (a) Gray-scale ultrasound of the fistulous communication between the left portal vein (long arrow) and left hepatic vein (short
arrow). (b) Color Doppler ultrasound image of the junctional fistulous communication point demonstrating inflow in the left portal vein
(long arrow) and outflow in the left hepatic vein (short arrow).
The abdominal examination was normal without hep-
atomegaly. No bruits were appreciable over the liver. Labora-
tory studies were significant for thrombocytopenia (platelet
count 1 × 10
9/L), normal serum liver transaminases, and
an arterial blood gases without metabolic acidosis. A 12-
lead electrocardiogram was also normal for his age. A
detailedechocardiogramconfirmedrighttoleftshuntingand
additionally demonstrated a large collateral arterial vessel
from the left subclavian artery that coursed anteriorly over
the heart before entering the liver vascular malformation.
ThedescendingaortaDopplersignalalsoraisedsuspicionfor
additional arterial supply to the vascular malformation.
An abdominal ultrasound (Figure 1), MR angiogram
(Figure 2), and CT with contrast of the chest and abdomen
wereobtainedtobettercharacterizethevascularlesion.These
studies demonstrated an abnormal vascular communication
in the left lobe of his liver between the left portal vein and
an enlarged left hepatic vein. The Doppler pattern showed
an arterialized waveform suggestive of an extraneous arterial
supply to the venous malformation, which was supported by
the MR findings demonstrating a change in caliber of the
subdiaphragmatic aorta, enlarged celiac artery, and enlarged
left internal mammary artery supplying parts of the lesion in
the left lobe of the liver. The low systemic vascular resistance
of the arterial-venous fistula was suspected to be responsible
f o rt h el a r g ec a r d i a cs h u n ta tt h ed u c t u sa r t e r i o s u sa n d
resulting high output heart failure.
At 6 days of age, to improve pulmonary artery blood
flow and balance the infant’s circulation, he was taken to the
interventionalradiologysuiteforpercutaneousembolization
of this vascular malformation (Figure 3). A terminal intra-
hepatic arterial structure that directly communicated with
the portal vein and hepatic vein fistula was visualized by
ultrasound. An arterialized waveform was seen in the fistu-
lous communication itself using Doppler. Under ultrasound
guidance, access was gained to the fistulous connection and
Figure 2: Coronal postcontrast twist sequence (time resolved
gadolinium enhanced MRI) with multiphase following intravenous
injection of gadopentetate dimeglumine. Arterial phase evaluation
of the abdomen demonstrated a definite change in caliber of the
abdominal aorta at the level of the midliver with narrowing of its
subdiaphragmatic portion (long arrow). Additionally, between the
IVCandtheaorta,intheregionoftheleftlobeoftheliver,avascular
structure fills the left lobe of the liver (short arrow), communicating
with a large left hepatic vein draining into the right atrium.
sheathswereplacedoverawireinthelefthepaticveinandthe
left portal vein. Amplatzer vascular plugs (St. Jude Medical,
St. Paul, MN), 8mm and 12mm, were used to occlude the
left hepatic vein outflow, and an 8mm Amplatzer vascular
plug was placed in the left portal vein. Coils were packed
betweentheAmplatzerplugsinthecommunicatingfistulous
junctional zone. The arterial vessels feeding into the fistulaCase Reports in Vascular Medicine 3
Figure 3: Percutaneous venogram demonstrating opacification of
the right portal vasculature (short arrow) and the left hepatic vein
(longarrow)fromamanualinjectionfollowingpercutaneousaccess
at the junctional fistulous communication point between the left
portal vein and left hepatic vein.
no longer directly communicated and had no outflow source
after occlusion and closure of the fistulous communication
a c r o s st h es e g m e n t .A sar e s u l t ,n oa r t e r i a ls i d ei n t e r v e n t i o n
was necessary.
Following the procedure, the inhaled nitric oxide was
weaned off and the infant was easily extubated to room
air. Subsequent follow-up Doppler US imaging showed no
further evidence of residual arterio-portal-venous shunting
with resolution of the multiple previously identified vascular
channels. The remaining underlying left hepatic parenchyma
had an otherwise normal sonographic appearance. A repeat
echocardiogram showed that the ductal level shunting was
exclusively left-to-right without additional signs of pul-
monary hypertension. The infant was discharged home at 12
days of age. By two months of age, his cardiac dimensions
h a de n t i r e l yn o r m a l i z e dw i t ho n l yat r i v i a lr e s i d u a ll e ft - t o -
rightductalshunting.Ahepaticultrasoundat4monthsofage
demonstratednoevidenceofrecurrentarterio-portal-venous
shunting. He had continued to achieve age appropriate
developmental milestones.
3. Discussion
C P S Sa r er a r ev a s c u l a rm a l f o r m a t i o n s .Th ec l i n i c a lp r e s e n -
tation of CPSS malformations varies from asymptomatic to
symptomatic and can be associated with serious compli-
cations, including neonatal cholestasis, hyperammonemia,
hypergalactosemia, and portosystemic encephalopathy, none
of which was manifested by this patient [3]. Decreased
liver perfusion due to vascular shunting can lead to growth
restriction [4] and portal hypertension [5].
Postnatal imaging tools to diagnose CPSS include US,
MRI/MRA, and CT. We found Doppler US, which demon-
strated an arterialized waveform, to be most useful in
determining that an arterial-to-venous shunt was present.
MRI/MRA, while confirming the presence of an arterial-to-
venousshunt,wasnomoreinformativethanUS,whereasCT
did not demonstrate an arterial component of the CPSS. In
most cases, Doppler US appears to be the favored imaging
modalityfordiagnosingCPSSsinceitdoesnotrequiremove-
ment of the patient to the scanner, expose the patient to
radiation, or require sedation of the patient and is relatively
inexpensive.
The association between chromosomal abnormalities,
including Down syndrome, and CPSS has been reported [6].
Although it has been postulated that the risk of congenital
vascular malformations is decreased with Down syndrome
due to the presence of vascular epithelial growth factor
inhibitors on chromosome 21 [6], these malformations can
o c c u ri nD o w ns y n d r o m ep a t i e n t s .I nt h ep r e s e n tc a s e ,a n
anomalousportalvenouscommunicationwasmaintainedby
anintrahepaticvenousfistulabetweentheleftportalveinand
left hepatic vein and was additionally supplied by systemic
arterial collateral vessels. This abnormal arteriovenous shunt
resulted in an abnormally low systemic vascular resistance
relative to normal postnatal pulmonary vascular resistance,
perpetuatingthefetalcirculationofaright-to-leftductallevel
shunt.Asaresult,thepatient’sinitialclinicalpresentationwas
consistent with PPHN, a syndrome characterized by marked
pulmonary hypertension that causes hypoxemia and right-
to-left extrapulmonary shunting of blood. Since neonates
with Down syndrome have a known increased incidence of
idiopathicPPHN,thePPHNinthiscasedidnotimmediately
suggest an abnormality such as CPSS. This finding supports
obtaining echocardiograms in infants with suspected PPHN
to identify cardiac and less common abnormalities, such as
the left subclavian artery collateral vessel connecting to the
l i v e rt h a tw a ss e e ni no u rc a s e .
Spontaneous portosystemic shunt closure can occur
within the first 2 years of age [1]. Asymptomatic shunts may
remain until childhood. However, in the setting of severe
pulmonary artery hypertension or right heart failure, closure
o ft h es h u n t se i t h e rb ye n d o v a s c u l a ro rs u r g i c a la p p r o a c h
should be considered. Franchi-Abella et al. have proposed
guidelines for the closure of CPSS in children [2].
Our patient was at risk for high output cardiac failure due
to increased venous return caused by the low resistance hep-
atic circulation. Percutaneous management is less invasive
than an open surgical approach and is therefore the preferred
treatment for CPSS malformations. Interventional radiology
successfully performed percutaneous embolization of the
fistulouscommunicationbetweentheinfant’slefthepaticand
portalveins.Embolizationofboththehepaticvenousoutflow
and theportalvenousconnectionswas performedto prevent
possible proliferation due to the additional arterial supply
of the vascular malformation. Acute portal hypertension has
been reported to be associated with portosystemic shunt
closure [7]. This complication may be detected by measuring
t h ep o r t a lp r e s s u r ep r i o rt os h u n tc l o s u r e( o c c l u s i o nt e s t ) .
It has been suggested that a single step endovascular shunt
closure should not be done for portal pressures greater than
32mmHg [8]. In cases of elevated portal pressures, a two-
step approach with surgical banding of the shunt followed
by endovascular closure is preferred [2]. Patients who do
not respond to these interventions and have persistent portal
hypertension may require a future liver transplant.4 Case Reports in Vascular Medicine
4. Conclusion
Although rare, infants with Down syndrome presenting with
PPHN may have underlying CPSS. Doppler ultrasonography
is useful in diagnosing CPSS in early infancy. Percutaneous
endovascular closure of the shunts has been reported as the
standard management of these malformations [2]. Subse-
quent patient followup with imaging and measuring serum
transaminases is needed due to an increase risk of portal
hypertension after shunt closure.
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